| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Korro Bio, Inc. | Director | Common Stock | 35.1K | $18.6K | $0.53 | Nov 3, 2023 | Direct |
| Korro Bio, Inc. | Director | Stock Option (Right to Buy) | 5.19K | Jun 11, 2024 | Direct | ||
| F-star Therapeutics, Inc. | Director | Common Stock | 0 | $7.12 | Mar 8, 2023 | Direct | |
| F-star Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Mar 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KRRO | Korro Bio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
| FREQ | Korro Bio, Inc. | Nov 3, 2023 | 3 | $0 | 4 | Nov 7, 2023 | Director |
| FREQ | Korro Bio, Inc. | Nov 3, 2023 | 0 | $0 | 3 | Nov 7, 2023 | Director |
| FSTX | F-star Therapeutics, Inc. | Mar 8, 2023 | 5 | -$740K | 4 | Mar 9, 2023 | Director |
| FSTX | F-star Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
| FSTX | F-star Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |
| FSTX | F-star Therapeutics, Inc. | Nov 20, 2020 | 1 | $0 | 4/A | Aug 24, 2021 | Director |